Signal
EMA updates paediatric investigation plans for multiple medicines across therapeutic areas
The European Medicines Agency (EMA) has issued recent decisions on paediatric investigation plans (PIPs) involving several medicines across diverse therapeutic areas including neurology, surgical and medical procedures, infectious diseases, and endocrine disorders....
rss
clinical_trialsregulationdrug_developmentsafety_signals
Evidence locked
Today's free sample is only available for the edition's flagship signal.
Evidence preview
- EMA paediatric investigation plans updatesema.europa.eu